Editorial: Malignant hyperthermia: a pharmacogenetic disease of skeletal and cardiac muscle.
D000251:Adenosine Triphosphatases / Q000378:metabolism; D001706:Biopsy; D002118:Calcium / Q000378:metabolism; D003402:Creatine Kinase / Q000378:metabolism; D005112:Extracorporeal Circulation; D006801:Humans; D008305:Malignant Hyperthermia / Q000188:drug therapy / Q000201:enzymology / Q000209:etiology / Q000235:genetics / Q000378:metabolism / Q000473:pathology / Q000628:therapy; D009132:Muscles / Q000378:metabolism* / Q000473:pathology; D009206:Myocardium / Q000378:metabolism*; D010597:Pharmacogenetics; D011342:Procainamide / Q000627:therapeutic use; D011343:Procaine / Q000627:therapeutic use
D011343:Procaine; D003402:Creatine Kinase; D000251:Adenosine Triphosphatases; D011342:Procainamide; D002118:Calcium